Clinical Trial

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Trial Details
NCT Number NCT06935552
Lead Sponsor Assiut University
Conditions Refractory Chronic Migraine
Enrollment 44 participants
Start Date 2025-06-01
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-20